Genpact (G) Initiated with Outperform Rating at Oppenheimer

Genpact (G) has been initiated today with a Outperform rating by the research analysts at Oppenheimer.  The firm has also placed a price target of $20 dollars on the company.

The company is currently trading above its 50 & 200-day moving averages.  The yearly high for Genpact is $18.71 with the low being $13.09 per share.  Gentech has a market cap of $3,584,000,000 with 221,150,000 shares outstanding.  The company is trading at an overall gain for 2011.

Genpact (G) a global leader in business process and technology management, offering a broad portfolio of enterprise and industry-specific services. We manage over 3,000 processes for more than 400 clients worldwide.